Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes.
Fiche publication
Date publication
septembre 2015
Journal
Annals of the rheumatic diseases
Auteurs
Membres identifiés du Cancéropôle Est :
Dr RAT Anne-Christine
Tous les auteurs :
Ruyssen-Witrand A, Guernec G, Nigon D, Tobon G, Jamard B, Rat AC, Vittecoq O, Cantagrel A, Constantin A
Lien Pubmed
Résumé
Using data for patients with early rheumatoid arthritis (RA) from the ESPOIR cohort, we aimed to evaluate the impact of remission versus low disease activity (LDA) by the Simple Disease Activity Index (SDAI) at 1 year on 3-year structural damage assessed by the modified Sharp-van der Heijde total score (mTSS) and functional impairment assessed by the Health Assessment Questionnaire Disability Index (HAQ-DI).
Mots clés
Adult, Antirheumatic Agents, therapeutic use, Arthritis, Rheumatoid, diagnostic imaging, Cohort Studies, Female, Foot Joints, diagnostic imaging, Hand Joints, diagnostic imaging, Humans, Linear Models, Male, Middle Aged, Patient Care Planning, Prospective Studies, Radiography, Remission Induction, Severity of Illness Index, Treatment Outcome
Référence
Ann. Rheum. Dis.. 2015 Sep;74(9):1676-83